Cite

HARVARD Citation

    Seshimo, H. et al. (2023). Topical application of imatinib mesylate suppresses vitamin D3 analog‐induced dermatitis in Balb/c mice. Experimental dermatology. 32 (4), pp. 413-424. [Online]. 
  
Back to record